ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0UNL Nektar Therapeutics

47.18
0.00 (0.00%)
01 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 165.44M307.71M1.19B114.62M152.92M101.91M92.06M90.12M
Operating Income -112.86M-43.66M687.93M-440.04M-379.92M-446.1M-313.73M-263.68M
Pre Tax Income -152.65M-96.08M682.73M-440.05M-443.95M-523.28M-364.98M-276.26M
Net Income -153.52M-96.69M681.31M-440.67M-444.44M-523.84M-368.2M-276.06M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.002-0.6063.926-2.497-2.468-2.824-1.953-1.447
EBIT -132.57M-62.53M687.93M-440.04M-379.92M-470.51M-310.41M-264.83M
EBITDA -97.5M-28.92M696.73M-429.04M-367.42M-433.1M-301.53M-179.37M

Your Recent History

Delayed Upgrade Clock